• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

croivalve

CroíValve reports first tricuspid coaptation valve implant as part of U.S. early feasibility study

October 24, 2024 By Sean Whooley

CroíValve today announced the first patient treated with its Duo transcatheter tricuspid coaptation valve system in the TANDEM II study. TANDEM II, an early feasibility study in the U.S., evaluates Duo in the treatment of severe tricuspid regurgitation (TR). Duo works in tandem with the native tricuspid valve to restore valve function. Delivered using percutaneous […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Implants, Replacement Heart Valves, Structural Heart Tagged With: croivalve

CroíValve raises $16M to support tricuspid coaptation valve

August 7, 2024 By Sean Whooley

CroíValve announced today that it closed a Series B financing round with proceeds totaling $16 million. The MedTech & Irrus Syndicates led the financing round for the Dublin, Ireland-based tricuspid regurgitation (TR) treatment developer. Current investors Ascentifi, Furthr, Broadview Ventures, Atlantic Bridge University Fund, Enterprise Ireland, Elkstone and SOSV also participated. New investor IAG Capital […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Funding Roundup, Replacement Heart Valves, Structural Heart Tagged With: ambulatory surgery centers (ASCs), croivalve

CroíValve reports positive first-in-human valve repair data

June 10, 2024 By Sean Whooley

CroíValve today announced favorable patient outcomes in a first-in-human clinical trial of its Duo tricuspid coaptation valve system. Professor Wojciech Wojakowski presented data looking at Duo in the treatment of tricuspid regurgitation (TR) at New York Valves 2024. Duo, a novel, transcatheter coaptation valve, works in tandem with the native tricuspid valve to restore valve […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: croivalve

CroíValve is set to challenge as tricuspid regurgitation treatment space heats up

April 19, 2024 By Sean Whooley

With Edwards and Abbott making recent waves in the tricuspid regurgitation (TR) treatment space, CroíValve hopes to pave its own way. Edwards’ Evoque valve became the first transcatheter therapy to receive FDA approval to treat TR in February. This month, Abbott became the second with its TriClip transcatheter edge-to-edge repair (TEER) system picking up an […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Implants, Replacement Heart Valves, Stents, Structural Heart Tagged With: croivalve

CroíValve wins FDA IDE for tricuspid heart valve

January 25, 2024 By Sean Whooley

CroíValve announced today that it began an early feasibility study for its Duo tricuspid coaptation valve system. The beginning of the study follows FDA investigational device (IDE) approval. Tandem II, a prospective, multi-center, non-randomized, single-arm study looks at the safety and performance of Duo in patients with severe or greater symptomatic tricuspid regurgitation (TR). Duo […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: croivalve, FDA

CroíValve raises more than $9M in Series A round

February 11, 2022 By Danielle Kirsh

CroíValve this week announced that it raised €8 million ($9 million) in a Series A fundraising round to support a feasibility clinical study of its tricuspid valve system. The Dublin-baed company designed its Duo coaptation valve system to treat tricuspid regurgitation (TR), which is a severe heart condition that occurs when the tricuspid valve fails […]

Filed Under: Cardiovascular Tagged With: croivalve

CroíValve adds $4.4m to initiate clinical trials

September 12, 2019 By Sean Whooley

CroíValve said today that it secured more than $4 million in additional financing as it develops a treatment for tricuspid regurgitation. The funding, which amounts to more than $4.4 million (€4 million) includes more than $2.7 million (€2.5 million) from the European Union under its Horizon 2020 SME Instrument grant. The remaining $1.7 million (€1.5 […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Funding Roundup, Implants, News Well, Replacement Heart Valves, Research & Development Tagged With: Broadview Ventures, croivalve

Tricuspid valve repair device maker CroíValve raises $4m

March 29, 2019 By Fink Densford

Early stage tricuspid valve repair device developer CroíValve has raised approximately $3.6 million (EU €3.2 million) in an oversubscribed seed financing round, according to a report from the Irish Times. CroíValve is developing a novel percutaneous solution intended to treat tricuspid regurgitation that seals the central gap between the native valve leaflets to prevent regurgitation, […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular Tagged With: croivalve

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy